Medicine and Dentistry
Neoplasm
100%
Breast Cancer
99%
Systematic Review
62%
Quadrantectomy
56%
Pancreaticoduodenectomy
49%
Ovarian Cancer
49%
Sentinel Lymph Node
49%
Surgical Margin
47%
Surgeon
39%
Meta-Analysis
35%
Indocyanine Green
34%
Health Care Cost
33%
Positron Emission Tomography
31%
Malignant Neoplasm
31%
Lymph Node
31%
Specific Tumor
29%
Radioactive Tracer
28%
Lymph Node Metastasis
28%
Breast Cancer Surgery
28%
Tumor Localization
25%
Cost-Effectiveness Analysis
24%
Prostate Cancer
24%
Quality Adjusted Life Year
24%
Postoperative Delirium
24%
Coronary Artery Disease
24%
Pancreas Fistula
24%
Folate Receptor 1
24%
Bacterial Infection
24%
Hope
24%
Pelvis
24%
Vasculotropin A
24%
Cervical Cancer
24%
Bevacizumab
24%
Nodular Melanoma
24%
Breast Carcinoma
24%
Sentinel Lymph Node Biopsy
24%
Retroperitoneal Lymph Node Dissection
24%
Intensive Care Unit
24%
Axillary Lymph Node
24%
Breast Tissue
22%
Diagnosis
21%
Breast Melanoma
19%
False Negative Result
16%
Optical Imaging
16%
Nonoxinol 9
15%
Positron Emission Tomography
15%
Surgery
15%
Lymph Duct
14%
Infection
14%
Metastatic Carcinoma
14%
Keyphrases
External Validation
42%
C-index
34%
Prediction Model
29%
Head-to-head Comparison
27%
Coronary Artery Disease
24%
Target Antigen
24%
Severe Complications
24%
Courier
24%
Web-based Nomogram
24%
First-in-human
24%
Tumor
24%
Intensive Care Unit Patients
24%
Well-defined
24%
Human Use
24%
Preclinical Research
24%
Prognosis Analysis
24%
Extended Pelvic Lymph Node Dissection
24%
External Validation Study
24%
Diagnostic Imaging
24%
Therapeutic Antibody
24%
Surgical Treatment
24%
Risk Model
24%
Therapeutic Use
24%
Antibody-based
24%
Delirium in Elderly
24%
Disease Diagnosis
24%
FDA-approved Drugs
24%
Teaching Qualifications
24%
Novel Antibodies
24%
Therapeutic Agents
24%
Pancreaticoduodenectomy
24%
Antigen Specificity
24%
Imaging Modalities
24%
Diagnostic Probe
24%
Postoperative Delirium
24%
Imaging Probe
24%
Risk Prediction Model
24%
Intraoperative Technique
24%
Safety Profile
24%
Multicolor Fluorescence Imaging
24%
Repurposing
24%
Tumor Mass
24%
Diagnostic Purposes
24%
Imaging Strategy
24%
Non-intensive Care Unit
24%
Cancer Identification
24%
Research Use
24%
Tumor-like
19%
Coronary Risk Factors
13%
Model Discrimination
13%